I think if they can take care of the CR shortfall before the end of the month plus have a solid investor partner to take this up i see this as our next short term catalyst.
I cant see us going alone through to approval, i would see it as a huge risk if we went along with shoestring budget mindset we have today to implement and market a product like this - id hope for large pharma partnership or TO in the next 18 months
I think if they can take care of the CR shortfall before the end...
-
- There are more pages in this discussion • 1,318 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
